Savant Capital LLC Has $5.58 Million Stock Position in Molina Healthcare, Inc $MOH

Savant Capital LLC lifted its position in Molina Healthcare, Inc (NYSE:MOH) by 153.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,140 shares of the company’s stock after purchasing an additional 17,634 shares during the quarter. Savant Capital LLC’s holdings in Molina Healthcare were worth $5,576,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. New York State Common Retirement Fund boosted its holdings in shares of Molina Healthcare by 35.9% in the 3rd quarter. New York State Common Retirement Fund now owns 139,557 shares of the company’s stock worth $26,706,000 after acquiring an additional 36,831 shares in the last quarter. Merit Financial Group LLC raised its position in Molina Healthcare by 289.3% in the 3rd quarter. Merit Financial Group LLC now owns 11,735 shares of the company’s stock valued at $2,246,000 after purchasing an additional 8,721 shares during the last quarter. Gibraltar Capital Management Inc. acquired a new position in Molina Healthcare in the third quarter worth $6,709,000. Cerity Partners LLC grew its holdings in shares of Molina Healthcare by 245.3% during the third quarter. Cerity Partners LLC now owns 80,608 shares of the company’s stock worth $15,425,000 after purchasing an additional 57,266 shares during the last quarter. Finally, Brighton Jones LLC increased its stake in shares of Molina Healthcare by 189.5% in the third quarter. Brighton Jones LLC now owns 13,148 shares of the company’s stock valued at $2,516,000 after buying an additional 8,607 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Key Stories Impacting Molina Healthcare

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Revenue beat and top‑line growth — Molina reported revenue of $11.38B for Q4, above consensus and up ~8.3% year‑over‑year, showing continued member/revenue scale. Press Release
• Neutral Sentiment: Analyses and metric comparisons — Several pieces (Zacks, SFGate) walk through how key metrics compared to Street estimates; useful for investors wanting detail on margins, membership and cost drivers. Zacks Analysis
• Negative Sentiment: Huge EPS miss — Q4 reported EPS of ($2.75) vs. consensus ~$0.43 and vs prior‑year $5.05, a shocking swing that triggered the initial selloff. Zacks Loss Report
• Negative Sentiment: Material downward guidance — Molina updated FY‑2026 EPS guidance to roughly $5 (vs. Street ~$12.95), signaling that Obamacare/individual market cost pressures will weigh all year. This guidance reduction is the primary driver of the larger share‑price decline. Reuters: Forecast Below Estimates
• Negative Sentiment: Analyst reaction — Bank of America reiterated a Sell and cut its price target to $145, reflecting lowered earnings expectations and policy/market uncertainty. Analyst downgrades amplify selling pressure. TipRanks / BofA
• Negative Sentiment: Market reaction and headlines — The stock plunged ~30%+ in after‑hours trading on the surprise loss, guidance cut and negative headlines (coverage notes and retail commentary). That immediate liquidity hit can extend intraday weakness. Benzinga

Insiders Place Their Bets

In other Molina Healthcare news, Director Richard M. Schapiro sold 357 shares of the stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $143.02, for a total value of $51,058.14. Following the transaction, the director owned 11,352 shares of the company’s stock, valued at approximately $1,623,563.04. This represents a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.10% of the company’s stock.

Analyst Ratings Changes

MOH has been the topic of several research reports. Jefferies Financial Group set a $160.00 price target on shares of Molina Healthcare in a research report on Tuesday, December 16th. Mizuho set a $220.00 target price on shares of Molina Healthcare in a research note on Friday, January 9th. Truist Financial set a $175.00 price target on shares of Molina Healthcare in a research note on Friday, October 24th. Barclays raised their price target on shares of Molina Healthcare from $144.00 to $164.00 and gave the company an “underweight” rating in a report on Monday, January 5th. Finally, The Goldman Sachs Group reduced their price objective on Molina Healthcare from $207.00 to $167.00 and set a “neutral” rating on the stock in a report on Friday, October 24th. Three research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $182.64.

Molina Healthcare Price Performance

Shares of MOH stock opened at $176.69 on Friday. Molina Healthcare, Inc has a 52-week low of $133.40 and a 52-week high of $359.97. The stock has a market cap of $9.58 billion, a PE ratio of 10.94 and a beta of 0.49. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.68 and a current ratio of 1.68. The firm’s 50 day moving average price is $173.55 and its two-hundred day moving average price is $171.21.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Thursday, February 5th. The company reported ($2.75) earnings per share for the quarter, missing analysts’ consensus estimates of $0.43 by ($3.18). Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The company had revenue of $11.38 billion during the quarter, compared to analyst estimates of $10.90 billion. During the same period last year, the company earned $5.05 EPS. The business’s revenue for the quarter was up 8.3% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, analysts forecast that Molina Healthcare, Inc will post 24.4 EPS for the current year.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.